Skip to main content
. 2021 Jun 4;8(7):ofab294. doi: 10.1093/ofid/ofab294

Table 3.

Outcomes

Outcome BEZ (n = 38) SoC (n = 56) P Value
CDI recurrence, No. (%)
 30 d 4 (11) 8 (14) .76
 90 d 6 (16) 16 (29) .13
Death, No. (%)
 30 d 0 3 (5) .27
 90 d 0 3 (5) .27
Hospital readmission, No. (%)
 30 d 9 (24) 19 (34) .29
 90 d 18 (47) 28 (50) .67
Heart failure exacerbation among those with baseline heart failure diagnosis, No. (%) 0 2 (8) .49

Abbreviations: BEZ, bezlotoxumab; CDI, Clostridioides difficile infection; SoC, standard of care.